Results 191 to 200 of about 33,638 (296)

Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations [PDF]

, 2016
Barbui, T, Barosi, G, Birgegård, G, Cervantes, F, Griesshammer, M, Harrison, C., Hehlmann, R, Kiladjian, J-J, Kröger, N, Marchetti, M, McMullin, M F, Passamonti, F, Vannucchi, A   +12 more
core   +1 more source

Evolution of WHO diagnostic criteria in "Classical Myeloproliferative Neoplasms" compared with the International Consensus Classification. [PDF]

Blood Cancer J
Thiele J, Kvasnicka HM, Gianelli U, Arber DA, Tefferi A, Vannucchi AM, Barbui T, Orazi A.   +7 more
europepmc   +1 more source

Model-Assisted Spleen Contouring for Assessing Splenomegaly in Myelofibrosis: A Fast and Reproducible Approach to Evaluate Progression and Treatment Response. [PDF]

J Clin Med
Sharbatdaran A, Cohen T, Dev H, Sattar U, Bazojoo V, Wang Y, Hu Z, Zhu C, He X, Romano D, Scandura JM, Prince MR.   +11 more
europepmc   +1 more source

Myelofibrosis presenting as chronic cholecystitis.

, 1996
P M Geddy, K R Wedgwood
openalex   +1 more source

A case of porphyria cutanea tarda in association with idiopathic myelofibrosis and CREST syndrome [PDF]

, 2001
S.C. Lee, Sook Jung Yun, J-B. Lee, S-S. Lee, Yu Hui Won   +4 more
openalex   +1 more source

Treatment of <i>JAK2</i> V617F-positive primary myelofibrosis and advanced chronic myelogenous leukemia with ruxolitinib and flumatinib: a case report. [PDF]

Ann Med Surg (Lond)
Zhu F, Wang H, Qiu L.
europepmc   +1 more source

Endoscopic Injection Sclerotherapy for Esophageal Varicereal Hemorrhage in a Patient with Portal Hypertension Due to Primary Myelofibrosis

, 1996
Masaki Takemori, Makiyo Okamoto, Masanori Yatou, Yoshitaka Ueno, Hiroshi Nakamura, Kouichi Suzuki, Ryuichi Takahashi   +6 more
openalex   +2 more sources

Development of Dermatomyositis in a Patient with Primary Myelofibrosis [PDF]

, 2001
Hülya Taşkapan, Şebnem Gürsoy, Mustafa Çetın, Oktay Oymak, Ömer Özbakır   +4 more
openalex   +1 more source

Safety and efficacy of combined ruxolitinib and decitabine in accelerated and blast-phase myeloproliferative neoplasms [PDF]

, 2018
Abboud, Camille N.
core   +1 more source

Primary myelofibrosis progression: a game of cellular telephone. [PDF]

Haematologica
Wadley L, Fleischman A.
europepmc   +1 more source